IRVINE, CA/ ACCESSWIRE/ September 6, 2023/ HippoFi, Inc. proudly announces a partnership with global medical technology leader ZIMMER BIOMET, aiming to redefine the spinal biologics landscape.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the best undervalued medical device stocks to buy now. On July 10, Needham ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Aziyo Biologics (ELUT – Research Report), Zimmer Biomet Holdings (ZBH – Research Report) and ...

Biomet’s subsidiary, Biomet Biologics, has enrolled the 1st subject into its multicenter, prospective, randomized, double-blind, placebo-controlled ...

Under the terms of the deal, Zimmer Biomet will make an upfront payment of $13.00 per share in cash, which represents an 8.3% premium to Paragon's closing price on Tuesday. Shares of Paragon 28 ...

WARSAW, Ind., June 10, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has ...

Orthobiologics Market Growth in Future Scope 2022-2028 | Zimmer Biomet Holdings, Inc., Bone Biologics Corp, Harvest Technologies Corporation, Globus Medical, Inc.

IRVINE, CA / ACCESSWIRE / September 6, 2023 / HippoFi, Inc. (OTC PINK:ORHB) proudly announces a partnership with global medical technology leader ZIMMER BIOMET, aiming to redefine the spinal ...